ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 226 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2018. The put-call ratio across all filers is 5.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $93,606,000 | +16.7% | 6,568,851 | -1.8% | 0.59% | +14.2% |
Q2 2018 | $80,242,000 | -6.7% | 6,686,811 | -4.0% | 0.51% | -2.7% |
Q1 2018 | $86,050,000 | -11.9% | 6,967,591 | +3.8% | 0.53% | -12.2% |
Q4 2017 | $97,705,000 | +13.5% | 6,715,086 | +11.0% | 0.60% | +17.9% |
Q3 2017 | $86,051,000 | +10.9% | 6,047,181 | -0.6% | 0.51% | +9.2% |
Q2 2017 | $77,626,000 | +1.3% | 6,083,536 | +0.6% | 0.47% | +5.0% |
Q1 2017 | $76,652,000 | +59.6% | 6,045,110 | +28.5% | 0.44% | +51.0% |
Q4 2016 | $48,020,000 | -7.9% | 4,703,240 | +18.8% | 0.29% | -10.1% |
Q3 2016 | $52,152,000 | +0.1% | 3,959,900 | -3.4% | 0.33% | +3.2% |
Q2 2016 | $52,084,000 | +21.1% | 4,101,075 | +26.0% | 0.32% | +25.3% |
Q1 2016 | $42,992,000 | +5.6% | 3,254,475 | +22.9% | 0.25% | +9.1% |
Q4 2015 | $40,716,000 | +21.8% | 2,647,348 | -1.8% | 0.23% | +25.4% |
Q3 2015 | $33,427,000 | -9.0% | 2,695,705 | +0.4% | 0.18% | -3.1% |
Q2 2015 | $36,725,000 | +14.9% | 2,684,592 | +0.5% | 0.19% | +15.1% |
Q1 2015 | $31,957,000 | – | 2,672,015 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 11,000,000 | $163,570,000 | 8.77% |
Blue Harbour Group | 7,262,346 | $107,991,000 | 8.08% |
RIVULET CAPITAL, LLC | 265,000 | $3,941,000 | 4.12% |
Breithorn Capital Management | 336,760 | $5,008,000 | 2.92% |
EMINENCE CAPITAL, LP | 7,791,132 | $115,854,000 | 2.56% |
Chinook Capital Management | 76,275 | $1,134,000 | 1.73% |
GARGOYLE INVESTMENT ADVISOR L.L.C. | 198,008 | $2,657,000 | 1.64% |
Adirondack Research & Management Inc. | 190,749 | $2,836,000 | 1.63% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 100,000 | $1,487,000 | 1.05% |
PRICE MICHAEL F | 477,500 | $7,100,000 | 0.94% |